SCARB1 rs5888 is associated with the risk of age-related macular degeneration susceptibility and an impaired macular area

2016 ◽  
Vol 38 (3) ◽  
pp. 233-237 ◽  
Author(s):  
Daiva Stanislovaitiene ◽  
Dalia Zaliuniene ◽  
Algimantas Krisciukaitis ◽  
Robertas Petrolis ◽  
Alina Smalinskiene ◽  
...  
Author(s):  
Sanjay Thokare

Age Related Macular Degeneration (ARMD) next to cataract is the leading cause  visual loss in elderly. My study is to focus on cleanical profile of Age Related Macular Degeneration with effective Ayurveda management to increasing in average longitivity of an individual with advance in science and technology along with traditional  management.In research scenario it has been demonstrated that choroidal neovascular lesion of Age Related Macular Degeneration. Account for most of severe loss of vision attributed to this condition. My study tries to give additional option and contribution of Ayurveda to patient affected with Age Related Macular Degeneration. Macula is area which correspond to centre of vision. There are two types Dry and Wet ARMD based on appearance of  exudates and tiny haemorrhage in the macular area . in wet AMD treatment of Raktpitta should be followed. Though  description of macular degeneration is not described is classics . Gradual loss of vision in Timira we can assume this regenerative pathology as Prakopita Vatalakshana in Drushti Mandala .  Inn proper Tarpak Kapha result in weakening of function and death of life sensing cells of macula . In dry Age Related Macular Degeneration this cells breakdown slowly and result in loss of central vision . These can be stated Kaphavata Drushtijanya Timira . In case of wet AMD abnormal blood vessels start to grow under macula and eventually bleed . This explains Raktpitta Drushti . Management of Age Related Macular Degeneration should be done on the principle of Vatavyadhi with Rasayan Chikitsa . 


2001 ◽  
Vol 58 (1) ◽  
pp. 28-35 ◽  
Author(s):  
Ursula Körner-Stiefbold

Die altersbedingte Makuladegeneration (AMD) ist eine der häufigsten Ursachen für einen irreversiblen Visusverlust bei Patienten über 65 Jahre. Nahezu 30% der über 75-Jährigen sind von einer AMD betroffen. Trotz neuer Erkenntnisse in der Grundlagenforschung ist die Ätiologie, zu der auch genetische Faktoren gehören, noch nicht völlig geklärt. Aus diesem Grund sind die Behandlungsmöglichkeiten zum jetzigen Zeitpunkt noch limitiert, so dass man lediglich von Therapieansätzen sprechen kann. Die derzeit zur Verfügung stehenden Möglichkeiten wie medikamentöse, chirurgische und laser- und strahlentherapeutische Maßnahmen werden beschrieben.


2018 ◽  
Author(s):  
Rebekah Stevens ◽  
Richard Cooke ◽  
Hannah Bartlett

Sign in / Sign up

Export Citation Format

Share Document